-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Coronavirus Disease 2019 (Covid-19) Vaccine in Middle East Respiratory Syndrome (MERS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Coronavirus Disease 2019 (Covid-19) Vaccine in Middle East Respiratory Syndrome (MERS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Coronavirus Disease 2019 (Covid-19) Vaccine in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dresbuxelimab in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dresbuxelimab in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dresbuxelimab in Kidney Cancer (Renal Cell Cancer) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dresbuxelimab in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dresbuxelimab in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dresbuxelimab in Non-Small Cell Lung Cancer Drug Details: Dresbuxelimab (AK-119)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efgartigimod Alfa in Antibody-Mediated Rejection (AMR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efgartigimod Alfa in Antibody-Mediated Rejection (AMR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efgartigimod Alfa in Antibody-Mediated Rejection (AMR) Drug Details: Efgartigimod...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nogapendekin Alfa in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nogapendekin Alfa in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nogapendekin Alfa in Metastatic Colorectal Cancer Drug Details: Nogapendekin...
-
Sector Analysis
mRNA Vaccines in Infectious Diseases Market Outlook and Trends by Opportunities, Challenges, Unmet Needs, and Competitive Landscape
mRNA Vaccines in Infectious Diseases Market Report Overview The first mRNA vaccines for COVID-19 gained authorization for use in December 2020. These vaccines have been proven highly successful clinically and commercially, dominating the COVID-19 vaccine market. Furthermore, the success of the COVID-19 mRNA vaccines has renewed interest in mRNA vaccines for a variety of other infectious diseases such as influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), Mpox, herpes, Zika virus, and Lyme disease. The report provides an assessment of the...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) Epidemiology Analysis and Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC) Report Overview In the 8MM, there were 1,097,467 diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) in 2022. The diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) will register an AGR of more than 2% during 2022-2032. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, NSCLC can begin anywhere in the lungs when the healthy cells that make up the lining of the lungs change and grow out...
-
Product Insights
NewAirway Management Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Airway Management Pipeline Market Report Overview Airway management refers to medical procedures performed for the prevention or alleviation of any obstruction in the airway. Airway management procedures are performed to open a pathway for maintaining or re-storing proper gas exchange between a patient's lungs and the atmosphere. This is accomplished with the use of an infraglottic device (Endotracheal tubes) supraglottic device (Laryngeal mask) or surgical method (Tracheostomy). The devices used for airway management are referred to as airway management devices....
-
Analyst Opinions
Online Travel Market Trends and Analysis by Advertising Activity, Challenges, Opportunities and Case Studies, 2023 Update
Online Travel Market Trends Analysis Report Overview The online travel market size in 2022 was estimated at $660.95 billion. The growth is attributed to the effective COVID-19 vaccination programs that contributed to the easing of travel restrictions. Moreover, COVID-19 accelerated the need for travel and tourism companies to adopt a digital strategy as the global pandemic highlighted the need to reduce physical contact, and consumers are still more likely than before to carry out transactions online. Travelers’ requirements are constantly...
-
Sector Analysis
Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Syringes, Needles, and Urinary Catheters Market Report Overview The syringes, needles, and urinary catheters market size was $25.28 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. The market for syringes, needles, and urinary catheters is profoundly intertwined with healthcare delivery and patient management. These medical devices serve various purposes, from administering medications and vaccines to facilitating urine drainage in individuals with specific medical conditions. Syringes, Needles, and Urinary Catheters Market...